Results 141 to 150 of about 7,362 (203)

Early Clinical Approach Prevents Severe Neurotoxicity Following Cobra Envenoming: An Integrated Experimental and Multi-Center Clinical Study in Thailand. [PDF]

Biomedicines
Lertsakulbunlue S, Chesor M, Promsorn P, Chuaikhongthong W, Khimmaktong W, Chantkran W, Chaisakul J.   +6 more
europepmc   +1 more source

Bispecific single-domain antibody (VHH) fused with human IgG1 Fc with dual specificity effectively neutralize Naja Kaouthia venom. [PDF]

PLoS Negl Trop Dis
Pothisamutyothin K, Sathorn S, Boonmee R, Thaveekarn W, Arunmanee W.   +4 more
europepmc   +1 more source

Differential Effects of Marimastat and Prinomastat on the Metalloprotease Activity of Various Snake Venoms. [PDF]

Toxins (Basel)
Khatibi M, Almeida JR, Gilabadi S, Ramírez D, Valenzuela-Hormazábal P, Patel K, Vaiyapuri S.   +6 more
europepmc   +1 more source

The unmet need for the mitigation of snakebite envenoming in India: a one health perspective. [PDF]

Trop Med Health
Allen S, Munshi H, Chakma JK.
europepmc   +1 more source

Management of Naja kaouthia Envenomation at a Quaternary Urban Medical Center: A Case Report. [PDF]

J Orthop Case Rep
Stump K, Talsania A, Sethi L, Burychka A, Solarz M.   +4 more
europepmc   +1 more source

Transcriptomic Insights Into the Evolution of Snake Venom: Mechanisms, Diversity, and Adaptation. [PDF]

Scientifica (Cairo)
Sofyantoro F, Kusuma WA, Wahyudi ST, Lumbanraja FR, Rahmawan H, Rustamaji HC, Kurniawan DW, Rastuti U, Putri WA, Wibowo WA, Priyono DS, Yudha DS, Raharjo S, Nuringtyas TR.   +13 more
europepmc   +1 more source

Development of a deep learning based framework for classification of Indian venomous snakes integrated with explainable artificial intelligence for primary and emergency care providers. [PDF]

PLoS Negl Trop Dis
Manna IIA, Wagle U, Balaji B, Lath V, Sampathila N, Upadya P S, Sirur FM.   +6 more
europepmc   +1 more source

Snake envenomation and acute kidney injury: a systematic review and meta-analysis. [PDF]

BMC Nephrol
Goumboundi IA, Taylor S, Ayerkain NL, Asum K, Oti MG, Afrifa J, Ephraim RKD.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Recombinant cobra venom factor

Molecular Immunology, 2004
Cobra venom factor (CVF) is the complement-activating protein from cobra venom. CVF is a three-chain protein that functionally resembles C3b, the activated form of complement component C3. Like C3b, CVF forms a C3/C5 convertase with factor B in the presence of factor D and Mg(2+).
Carl-Wilhelm Vogel, David C Fritzinger, Brian E Hew   +2 more
exaly   +3 more sources

Hybrid proteins of Cobra Venom Factor and cobra C3: Tools to identify functionally important regions in Cobra Venom Factor

Toxicon, 2012
Cobra Venom Factor (CVF) is the complement-activating protein in cobra venom. CVF is structurally and functionally highly homologous to complement component C3. CVF, like C3b, the activated form of C3, forms a bimolecular complex with Factor B in serum, called C3/C5 convertase, an enzyme which activates complement components C3 and C5. Despite the high
Brian E Hew, David C Fritzinger, Carl-Wilhelm Vogel   +2 more
exaly   +3 more sources